Jorges E. Cortes, MD

Jorge E. Cortes, MD, discusses the frontline treatment options for patients with chronic myeloid leukemia.

Jorge E. Cortes, MD, discusses the results from the ENESTFreedom study, which evaluated the use of nilotinib as a treatment for patients with BCR-ABL1&ndash;positive chronic myeloid leukemia in the chronic phase.<br /> &nbsp;